Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

26

Revenue 2017

Victoza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Victoza was produced by Novo Nordisk.

Novo Nordisk’s semaglutide obesity trial hits the mark

Novo Nordisk’s semaglutide obesity trial hits the mark The positive data in obesity is another boost for Novo as it tries to position semaglutide as a successor to Victoza, which pulled in $3.8bn in sales for the Danish ... Victoza’s patents are also being challenged by generic rivals - including Teva in

Takeda and Zinfandel abandon Alzheimer’s drug

Takeda and Zinfandel abandon Alzheimer’s drug Meanwhile, other diabetes drugs have also been tested for activity in AD, including Novo Nordisk's Victoza (liraglutide) which seemed to reduce amyloid plaque formation but had no effect on cognitive

Novo Nordisk gets FDA nod for once-weekly rival to Lilly’s Trulicity

Novo Nordisk gets FDA nod for once-weekly rival to Lilly’s Trulicity of the year mainly because of its dosing advantage versus daily GLP-1 drugs like Novo’s Victoza (liraglutide).

J&J seeks US OK to add CV claim to Invokana label

J&J seeks US OK to add CV claim to Invokana label If approved the treatment could better compete with rivals Jardiance and Victoza. ... label in the wake of the EMPA-REG study, as well as Novo Nordisk’s GLP-1 agonist Victoza (liraglutide) which was given a cardiovascular disease reduction indication

Novo's semaglutide beats Lilly's Trulicity in diabetes contest

Novo's semaglutide beats Lilly's Trulicity in diabetes contest Trulicity's growth stems from its once-weekly dosing, which has proved a popular alternative to daily GLP-1 agonists such as Novo's Victoza (liraglutide).

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics